These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9810896)

  • 21. Pyoderma Gangrenosum:Recognition and Management.
    Pompeo MQ
    Wounds; 2016 Jan; 28(1):7-13. PubMed ID: 26779805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of human intravenous immune globulin in pyoderma gangrenosum.
    Gupta AK; Shear NH; Sauder DN
    J Am Acad Dermatol; 1995 Jan; 32(1):140-2. PubMed ID: 7822511
    [No Abstract]   [Full Text] [Related]  

  • 23. Pyoderma gangrenosum with spleen involvement and monoclonal IgA gammopathy.
    Mijuşković ZP; Zecević RD; Pavlović MD
    J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):697-9. PubMed ID: 15482299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
    Funayama Y; Kumagai E; Takahashi K; Fukushima K; Sasaki I
    Dis Colon Rectum; 2009 Feb; 52(2):311-4. PubMed ID: 19279428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Keratin Gel as an Adjuvant in the Treatment of Recalcitrant Pyoderma Gangrenosum Ulcers: A Case Report.
    Paulsen E; Bygum A
    Acta Derm Venereol; 2019 Feb; 99(2):234-235. PubMed ID: 30393816
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravenous immunoglobulin is effective as a sole immunomodulatory agent in pyoderma gangrenosum unresponsive to systemic corticosteroids.
    Suchak R; Macedo C; Glover M; Lawlor F
    Clin Exp Dermatol; 2007 Mar; 32(2):205-7. PubMed ID: 17342799
    [No Abstract]   [Full Text] [Related]  

  • 27. Pyoderma gangrenosum: an inflammatory ulcer.
    Samuel J; Williams C
    J Wound Care; 1996 Jul; 5(7):314-8. PubMed ID: 8954419
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful treatment of pyoderma gangrenosum with intravenous immunoglobulins during pregnancy.
    Erfurt-Berge C; Herbst C; Schuler G; Bauerschmitz J
    J Cutan Med Surg; 2012; 16(3):205-7. PubMed ID: 22713447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids.
    Doren EL; Aya-ay ML
    Aesthet Surg J; 2014 Mar; 34(3):394-9. PubMed ID: 24448967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyoderma gangraenosum: exploring the treatment options.
    Kelly J
    J Wound Care; 2001 Apr; 10(4):125-8. PubMed ID: 12964317
    [No Abstract]   [Full Text] [Related]  

  • 31. Multimodal therapy of idiopathic pyoderma gangrenosum.
    Sharon V; Burrall B; Patel F; He Y; Konia T; Villalobos IB; Maverakis E
    Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of conservative medical treatment for pyoderma gangrenosum.
    Fioramonti P; Onesti MG; Fino P; Di Ronza S; Sorvillo V; Persichetti P
    In Vivo; 2012; 26(1):157-9. PubMed ID: 22210732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superficial granulomatous pyoderma in a patient with ulcerative colitis successfully treated with cyclosporine A.
    Żychowska M; Maj J
    Int J Dermatol; 2019 Jun; 58(6):733-735. PubMed ID: 30460989
    [No Abstract]   [Full Text] [Related]  

  • 34. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
    Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
    Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of wound breakdown caused by pyoderma gangrenosum after total knee arthroplasty.
    Nakajima N; Ikeuchi M; Izumi M; Kuriyama M; Nakajima H; Tani T
    Knee; 2011 Dec; 18(6):453-5. PubMed ID: 20643552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Treatment-resistant pyoderma gangrenosum.
    Kosari P; Feldman SR
    Dermatol Online J; 2012 Apr; 18(4):8. PubMed ID: 22559023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pustular pyoderma gangrenosum.
    Leger M; Newlove T; Chu J; Meehan S; Stein J
    Dermatol Online J; 2011 Oct; 17(10):17. PubMed ID: 22031643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyoderma gangrenosum after breast surgery: A systematic review.
    Ehrl DC; Heidekrueger PI; Broer PN
    J Plast Reconstr Aesthet Surg; 2018 Jul; 71(7):1023-1032. PubMed ID: 29748073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maggots do not survive in pyoderma gangrenosum.
    Renner R; Treudler R; Simon JC
    Dermatology; 2008; 217(3):241-3. PubMed ID: 18663307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyoderma gangrenosum in a patient with collagenous colitis.
    Batra AK; Levey JM; Trister J; Patwardhan R
    J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S277-9. PubMed ID: 14576653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.